Altering the rehabilitation environment to improve stroke survivor activity: A Phase II trial.
Stroke
activity
clinical trial
environmental enrichment
recovery
rehabilitation
Journal
International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
pubmed:
20
3
2021
medline:
23
3
2022
entrez:
19
3
2021
Statut:
ppublish
Résumé
Environmental enrichment involves organization of the environment and provision of equipment to facilitate engagement in physical, cognitive, and social activities. In animals with stroke, it promotes brain plasticity and recovery. To assess the feasibility and safety of a patient-driven model of environmental enrichment incorporating access to communal and individual environmental enrichment. A nonrandomized cluster trial with blinded measurement involving people with stroke ( The experimental group ( This patient-driven model of environmental enrichment was feasible and safe. However, the very modest increase in activity by people with stroke, and the lack of benefit in clinical outcomes three months after stroke do not provide justification for an efficacy trial.
Sections du résumé
BACKGROUND
Environmental enrichment involves organization of the environment and provision of equipment to facilitate engagement in physical, cognitive, and social activities. In animals with stroke, it promotes brain plasticity and recovery.
AIMS
To assess the feasibility and safety of a patient-driven model of environmental enrichment incorporating access to communal and individual environmental enrichment.
METHODS
A nonrandomized cluster trial with blinded measurement involving people with stroke (
RESULTS
The experimental group (
CONCLUSIONS
This patient-driven model of environmental enrichment was feasible and safe. However, the very modest increase in activity by people with stroke, and the lack of benefit in clinical outcomes three months after stroke do not provide justification for an efficacy trial.
Identifiants
pubmed: 33739202
doi: 10.1177/17474930211006999
doi:
Types de publication
Clinical Trial
Clinical Trial, Phase II
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM